Table of Contents

company-logo

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental synthetic agents; and in vitro diagnostic reagents and medical devices. Vcanbio Cell & Gene Engineering Corp., Ltd was founded in 1992 and is based in Tianjin, the People's Republic of China.

Vcanbio Cell & Gene Engineering Dividend Announcement

• Vcanbio Cell & Gene Engineering announced a annually dividend of ¥0.02 per ordinary share which will be made payable on . Ex dividend date: 2001-08-10
• Vcanbio Cell & Gene Engineering's trailing twelve-month (TTM) dividend yield is -%
• Vcanbio Cell & Gene Engineering's payout ratio for the trailing twelve months (TTM) is 0.62%

Vcanbio Cell & Gene Engineering Dividend History

Ex-Div dateDividend amountDividend typePay date
2001-08-10¥0.02annually
1998-07-06¥0.09annually
1995-04-25¥0.28annually

Vcanbio Cell & Gene Engineering Dividend per year

Vcanbio Cell & Gene Engineering Dividend Yield

Vcanbio Cell & Gene Engineering current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Vcanbio Cell & Gene Engineering stock? Use our calculator to estimate your expected dividend yield:

Vcanbio Cell & Gene Engineering Financial Ratios

P/E ratio99.70
PEG ratio24.03
P/B ratio2.96
ROE2.95%
Payout ratio0.62%
Current ratio1.66
Quick ratio1.48
Cash Ratio0.97

Vcanbio Cell & Gene Engineering Dividend FAQ

Does Vcanbio Cell & Gene Engineering stock pay dividends?
Vcanbio Cell & Gene Engineering does not currently pay dividends to its shareholders.
Has Vcanbio Cell & Gene Engineering ever paid a dividend?
No, Vcanbio Cell & Gene Engineering has no a history of paying dividends to its shareholders. Vcanbio Cell & Gene Engineering is not known for its dividend payments.
Why doesn't Vcanbio Cell & Gene Engineering pay dividends?
There are several potential reasons why Vcanbio Cell & Gene Engineering would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Vcanbio Cell & Gene Engineering ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Vcanbio Cell & Gene Engineering has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Vcanbio Cell & Gene Engineering a dividend aristocrat?
Vcanbio Cell & Gene Engineering is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Vcanbio Cell & Gene Engineering a dividend king?
Vcanbio Cell & Gene Engineering is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Vcanbio Cell & Gene Engineering a dividend stock?
No, Vcanbio Cell & Gene Engineering is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Vcanbio Cell & Gene Engineering stocks?
To buy Vcanbio Cell & Gene Engineering you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Vcanbio Cell & Gene Engineering stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.